Cargando…

The Rationale for the Dual-Targeting Therapy for RSK2 and AKT in Multiple Myeloma

Multiple myeloma (MM) is characterized by remarkable cytogenetic/molecular heterogeneity among patients and intraclonal diversity even in a single patient. We previously demonstrated that PDPK1, the master kinase of series of AGC kinases, is universally active in MM, and plays pivotal roles in cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Isa, Reiko, Horinaka, Mano, Tsukamoto, Taku, Mizuhara, Kentaro, Fujibayashi, Yuto, Taminishi-Katsuragawa, Yoko, Okamoto, Haruya, Yasuda, Shusuke, Kawaji-Kanayama, Yuka, Matsumura-Kimoto, Yayoi, Mizutani, Shinsuke, Shimura, Yuji, Taniwaki, Masafumi, Sakai, Toshiyuki, Kuroda, Junya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949999/ https://www.ncbi.nlm.nih.gov/pubmed/35328342 http://dx.doi.org/10.3390/ijms23062919

Ejemplares similares

P1226: BTG2, A NOVEL TARGET OF MIR-17-92, REGULATES B CELL RECEPTOR SIGNALING IN MANTLE CELL LYMPHOMA
por: Kawaji-Kanayama, Yuka, et al.
Publicado: (2023)

Serine‐227 in the N‐terminal kinase domain of RSK2 is a potential therapeutic target for mantle cell lymphoma
por: Matsumura‐Kimoto, Yayoi, et al.
Publicado: (2020)

Gastric Myeloid Sarcoma Mimicking a Scirrhous Gastric Cancer
por: Taminishi-Katsuragawa, Yoko, et al.
Publicado: (2021)

Combination of Bone Marrow Biopsy and Flow Cytometric Analysis: The Prognostically Relevant Central Approach for Detecting Bone Marrow Invasion in Diffuse Large B-Cell Lymphoma
por: Okamoto, Haruya, et al.
Publicado: (2021)

Aberrant BUB1 Overexpression Promotes Mitotic Segregation Errors and Chromosomal Instability in Multiple Myeloma
por: Fujibayashi, Yuto, et al.
Publicado: (2020)

Prognostic impact of resistance to bortezomib and/or lenalidomide in carfilzomib‐based therapies for relapsed/refractory multiple myeloma: The Kyoto Clinical Hematology Study Group, multicenter, pilot, prospective, observational study in Asian patients
por: Kawaji‐Kanayama, Yuka, et al.
Publicado: (2021)

Human herpesvirus-6 pneumonitis in a patient with follicular lymphoma following immunochemotherapy with rituximab
por: Kuwahara-Ota, Saeko, et al.
Publicado: (2018)

Chromosomal abnormality variation detected by G‐banding is associated with prognosis of diffuse large B‐cell lymphoma treated by R‐CHOP‐based therapy
por: Mizuno, Yoshimi, et al.
Publicado: (2018)

P1127: WATCHFUL WAITING IS AN ACCEPTABLE TREATMENT OPTION FOR PRIMARY OCULAR ADNEXAL MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA: A RETROSPECTIVE STUDY
por: Mizuhara, K., et al.
Publicado: (2022)

Clinical Implication of the Effect of the Production of Neutralizing Antibodies Against SARS-Cov-2 for Chronic Immune Thrombocytopenia Flare-Up Associated with COVID-19 Infection: A Case Report and the Review of Literature
por: Maekura, Chika, et al.
Publicado: (2022)

Watchful waiting is an acceptable treatment option for asymptomatic primary ocular adnexal mucosa‐associated lymphoid tissue lymphoma: A retrospective study
por: Mizuhara, Kentaro, et al.
Publicado: (2022)

Impact of Treatment with Anti-CD20 Monoclonal Antibody on the Production of Neutralizing Antibody Against Anti–SARS-CoV-2 Vaccination in Mature B-Cell Neoplasms
por: Onishi, Akio, et al.
Publicado: (2023)

Chronic Invasive Fungal Rhinosinusitis with Atypical Clinical Presentation in an Immunocompromised Patient
por: Kawaji-Kanayama, Yuka, et al.
Publicado: (2020)

Reduced-Intensity Allogeneic Stem Cell Transplantation for Co-Emergence of Chemotherapy-Refractory Follicular Lymphoma and Therapy-Related Myelodysplastic Syndrome
por: Shimura, Yuji, et al.
Publicado: (2014)

Tuberculosis Peritonitis During Treatment of Polycythemia Vera with Ruxolitinib
por: Sakiyama, Emiko, et al.
Publicado: (2020)

Progressive Multifocal Leukoencephalopathy Initially Suspected As Brain Relapse From Classical Hodgkin’s Lymphoma
por: Onishi, Akio, et al.
Publicado: (2023)

8q24 amplified segments involve novel fusion genes between NSMCE2 and long noncoding RNAs in acute myelogenous leukemia
por: Chinen, Yoshiaki, et al.
Publicado: (2014)

Management of Acquired Factor X Deficiency Caused by In Vitro Non-neutralizing Anti-factor X Autoantibodies with Pre-emptive Corticosteroid Therapy
por: Onishi, Akio, et al.
Publicado: (2023)

High-risk follicular lymphomas harbour more somatic mutations including those in the AID-motif
por: Tsukamoto, Taku, et al.
Publicado: (2017)

Imaging flow cytometry-based multiplex FISH for three IGH translocations in multiple myeloma
por: Tsukamoto, Taku, et al.
Publicado: (2023)

Myeloid zinc finger 1 mediates sulindac sulfide-induced upregulation of death receptor 5 of human colon cancer cells
por: Horinaka, Mano, et al.
Publicado: (2014)

rSK1 in Rat Neurons: A Controller of Membrane rSK2?
por: Autuori, Eleonora, et al.
Publicado: (2019)

RSK1 and RSK2 serine/threonine kinases regulate different transcription programs in cancer
por: Yang, Won Seok, et al.
Publicado: (2023)

RSK Isoforms in Acute Myeloid Leukemia
por: Youn, Minyoung, et al.
Publicado: (2021)

Regulation of p90RSK phosphorylation by SARS‐CoV infection in Vero E6 cells
por: Mizutani, Tetsuya, et al.
Publicado: (2006)

The ribosomal S6 kinase 2 (RSK2)–SPRED2 complex regulates the phosphorylation of RSK substrates and MAPK signaling
por: Lopez, Jocelyne, et al.
Publicado: (2023)

Novel RAF/MEK inhibitor CH5126766/VS‐6766 has efficacy in combination with eribulin for the treatment of triple‐negative breast cancer
por: Ono, Hisako, et al.
Publicado: (2021)

Discovery of cancer-preventive juices reactivating RB functions
por: Masuda, Mitsuharu, et al.
Publicado: (2023)

Cervical Local Cytokine Release Syndrome Following Chimeric Antigen Receptor T-cell Therapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
por: Inoue, Yu, et al.
Publicado: (2023)

RSK2 Is a Modulator of Craniofacial Development
por: Laugel-Haushalter, Virginie, et al.
Publicado: (2014)

RSK-c-Fos in KSHV lytic progression
por: Li, Xiaojuan, et al.
Publicado: (2015)

Identifying requirements for RSK2 specific inhibitors
por: Wright, Eric B., et al.
Publicado: (2021)

Crucial roles of RSK in cell motility by catalysing serine phosphorylation of EphA2
por: Zhou, Yue, et al.
Publicado: (2015)

Detection of novel and recurrent conjoined genes in non-Hodgkin B-cell lymphoma
por: Matsumoto, Yosuke, et al.
Publicado: (2021)

Recruitment and Activation of RSK2 by HIV-1 Tat
por: Hetzer, Claudia, et al.
Publicado: (2007)

RSK1 activation promotes invasion in nodular melanoma
por: Salhi, Amel, et al.
Publicado: (2015)

Role of p90RSK in Kidney and Other Diseases
por: Lin, Ling, et al.
Publicado: (2019)

Effect of RSK4 on biological characteristics of colorectal cancer
por: Ye, Qingqing, et al.
Publicado: (2018)

Effect of RSK4 on Biological Characteristics of Gastric Cancer
por: Hu, Cong, et al.
Publicado: (2020)

RSK1 SUMOylation is required for KSHV lytic replication
por: Liu, Zhenshan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ou3ellbdmt7gmblv9q2pf8ngvk